Cargando…
Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome
BACKGROUND: A previous study evaluated the intra-tumoral heterogeneity observed in the uptake of F-18 fluorodeoxyglucose (FDG) in pre-treatment positron emission tomography (PET) scans of cancers of the uterine cervix as an indicator of disease outcome. This was done via a novel statistic which oste...
Autores principales: | Brooks, Frank J, Grigsby, Perry W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130664/ https://www.ncbi.nlm.nih.gov/pubmed/21658258 http://dx.doi.org/10.1186/1748-717X-6-69 |
Ejemplares similares
-
FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement
por: Brooks, Frank J, et al.
Publicado: (2013) -
Quantification of heterogeneity observed in medical images
por: Brooks, Frank J, et al.
Publicado: (2013) -
The prognostic value of PET and PET/CT in cervical cancer
por: Grigsby, Perry W.
Publicado: (2008) -
Low-Order Non-Spatial Effects Dominate Second-Order Spatial Effects in the Texture
Quantifier Analysis of 18F-FDG-PET Images
por: Brooks, Frank J., et al.
Publicado: (2015) -
Measuring tumor metabolic heterogeneity on positron emission tomography: utility in cervical cancer
por: Lai, Chyong-Huey
Publicado: (2016)